Search for: "APOTEX CORP." Results 241 - 260 of 333
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2010, 7:26 am by Dennis Crouch
Apotex, Inc., 623 F.Supp.2d 579, 598-600 (D.N.J.2009); Alza Corp. v. [read post]
27 Dec 2009, 8:32 pm by Patent Docs
KG • Defendants: Apotex Inc.; Apotex Corp. [read post]
8 Nov 2009, 9:28 pm
• Defendants: Apotex Inc.; Apotex Corp. [read post]
2 Nov 2009, 1:24 pm
Iqbal and Bell Atlantic Corp. v. [read post]
1 Oct 2009, 2:14 am
Apotex Corp., 2008 WL 2047979 (S.D. [read post]
15 Sep 2009, 10:54 pm
Apotex Corp., 439 F.3d 1312, 1317 (Fed. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
5 Jul 2009, 9:13 pm
• Defendants: Apotex Inc.; Apotex Corp. [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA Law Blog) Plavix… [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA Law Blog) Plavix… [read post]
27 May 2009, 5:27 am
(Patent Office’s rejection of Glivec’s second variant) (Spicy IP) (Spicy IP) Sweden: Anti-counterfeit barcode technology trialled in Sweden (Managing Intellectual Property) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Inventive Step) (Holman's Biotech IP Blog) US: Biotech sector highly critical of Commission’s… [read post]